Related Experiment Videos
[Surgical treatment for prosthetic valve endocarditis]
S Hirose1, K Nakano, Y Kosakai
1Department of Cardiovascular Surgery, National Cardiovascular Center, Osaka.
Journal of Cardiology
|July 17, 1998
Summary
Surgical treatment for prosthetic valve endocarditis (PVE) in 21 patients showed a 24% mortality rate. Early diagnosis and surgical intervention are crucial for better outcomes in PVE patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Treatment
Context:
- Prosthetic valve endocarditis (PVE) poses significant risks post-cardiac surgery.
- This study analyzes surgical outcomes for PVE patients over a four-year period.
Purpose:
- To evaluate the clinical characteristics, causative organisms, and outcomes of surgical treatment for prosthetic valve endocarditis (PVE).
- To highlight the importance of timely diagnosis and surgical intervention in managing PVE.
Summary:
- Twenty-one patients with PVE underwent surgical treatment between 1993 and 1997.
- Staphylococcus epidermidis was the most common pathogen. Early PVE occurred in 4 cases, late PVE in 17.
- The hospital mortality rate was 24%, with intramyocardial abscesses found in 3 autopsy cases. Reoperation was needed for 4 patients.
Impact:
- Findings underscore the need for prompt diagnosis and surgical management to reduce mortality and morbidity associated with PVE.
- Accurate identification of pathogens, particularly from operative tissue cultures, is essential for effective treatment strategies.